AI assistant
Vivesto — Major Shareholding Notification 2010
Feb 5, 2010
3124_iss_2010-02-05_fa83161e-395d-4565-bbb0-6682402af78c.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
Issuer Vivesto AB
Holder
Oasmia SA
Instrument
| Instrument | Aktier SE0000722365 | |
|---|---|---|
| Before the transaction | ||
| Shares | Data not given* | |
| Voting rights | Data not given* | |
| Transaction | ||
| Reason for major shareholding notification New share issue | ||
| Date | 30/12/2009 | |
| Limit for number of shares | 66 2/3 % | |
| Limit for number of votes | 66 2/3 % | |
| After the transaction | ||
| Quantity | ||
| Shares | 24,163,425 | |
| Directly held voting rights | 24,163,425 | |
| Indirectly held voting rights | 0 | |
| Percentage | ||
| Directly held shares | 64.26 % | |
| Directly held voting rights | 64.26 % | |
| Indirectly held voting rights | 0 % | |
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
|
|---|---|---|
| Shares |
Instruments - FITA Ch. 4, section 2, first paragraph, line 2 Instruments - FITA Ch. 4, section 2, first paragraph, line 3
-
Physically settled
-
Cash settled
Total
Group total holdings
Voting rights 24,163,425 Percentage of voting rights 64.26
Notes (other relevant informations according to law)
Oasmia S.A.:s aktieinnehav i Oasmia Pharmaceutical AB har inte förändrats p.g.a. en transaktion från Oasmia S.A.:s sida. Förändringen i aktieinnehavet är hänförlig till en riktad emission till ett begränsat antal institutionella investerare. Oasmia S.A. har ej deltagit i den emissionen. I och med emissionen har huvudägaren Oasmia S.A.:s aktieinnehav kommit att understiga 66 procent av samtliga aktier och röster i Oasmia Pharmaceutical AB.
Published
05/02/2010 11:40
Contact
Name Maria Lundén
Phone 018-505440 Email [email protected]
*Source of information has chosen not to submit the data
CLOSE PRINT
[email protected] Tfn 08-408 980 37 Fax 08-24 39 25